CelerisTx
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
585 Glenwood Ave, Menlo Park, California...Website
www.celeristx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About CelerisTx
Founded in 2020, CelerisTx is a US-Austrian partially integrated drug discovery company focused on AI-driven development of novel degrader molecules that enable medicinal chemistry and drug design in the field of targeted protein degradation. CelerisTx develops the Celeris One platform, a closed-loop discovery engine that predicts biomolecular interactions, generates new chemical entities that meet relevant degrader success criteria, and extends this knowledge to synthesis and biochemical validation. The application of this discovery engine promises to streamline the way potent degraders are discovered while increasing productivity in upstream research and development. CelerisTx partners with pharma and biotech companies and develops its drug pipeline in the areas of neurodegenerative diseases and oncology.Explore more
CelerisTx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CelerisTx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on CelerisTx recently announced quarterly report
Click to see if CelerisTx had a recent Job posting/layoffs
Check if CelerisTx has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if CelerisTx is spiking on competitors!
CelerisTx, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when CelerisTx launches new products
Funding: Get notified immidiatlly once CelerisTx has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at CelerisTx
Recommended Actions
Find VP level buyers at CelerisTx
Find more new buyers
Compare Similar Companies to CelerisTx
Compare insights from companies similar to CelerisTx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CelerisTx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CelerisTx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CelerisTx.
CelerisTx financials insights
Gather financial insights about CelerisTx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$4.4M
Series A
$22M
CelerisTx Tech Stack
A closer look at the technologies used by CelerisTx
Most Recent Scoops
Open Position
Open Position
Funding
New Hire
Executive Move
Funding
CelerisTx News & Media
Celeris Therapeutics Appoints James Field as Board Director, Bringing Expertise in TechBio Scaling, Robotics, and AI
LONDON, UK, September 15, 2023 /EINPresswire.com/ -- Celeris Therapeutics, the pioneer in AI-driven degrader discovery, is excited to announce the appointment of James Field as a Board Director. With a proven track record in scaling up TechBio companies …Celeris Therapeutics to receive 12.5 million Euros in funding from the European Innovation Council
GRAZ, STYRIA, AUSTRIA, October 19, 2022 /EINPresswire.com/ -- CelerisTx, the pioneer in AI-driven degrader design, today announces funding from the European Innovation Council (EIC). The company will receive a total of EUR 12.5 million through the …Celeris Therapeutics Announces Key Management Promotion
Dr. Markus Muellner Promoted to Chief Scientific Officer MENLO PARK, CALIFORNIA, USA, June 14, 2022 /EINPresswire.com/ -- Celeris Therapeutics, Inc., the pioneer in AI-driven proximity-inducing compound (PIC) design, today announced the promotion of Dr. …CelerisTx announces $4.4m financing to advance pipeline of novel proximity inducing compound
Celeris Therapeutics, the PIC™ engineering company, announces the closing of their $4.4m USD Series Seed Financing round.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CelerisTx
Sign Up For FreeTo access detailed company insights
Founded in 2020, CelerisTx is a US-Austrian partially integrated drug discovery company focused on AI-driven development of novel degrader molecules that enable medicinal chemistry and drug design in the field of targeted protein degradation. CelerisTx develops the Celeris One platform, a closed-loop discovery engine that predicts biomolecular inte... Read More
